JAK Inhibition in STAT1 Gain-of-Function-Associated Histoplasmosis and HLH
Journal of Clinical Immunology · 2025-12 · 45 (1)
DOI: 10.1007/s10875-025-01900-3 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Clinical Immunology, online erschienen am 05.11.2025. Verfasst von Jenny Patel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Washington University in Saint Louis, Box 8116, St. Louis, MO, 63110, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Washington University in Saint Louis, Box 8116, St. Louis, MO, 63110, USA.
- Department of Pediatrics, Washington University in Saint Louis, Box 8116, St. Louis, MO, 63110, USA. maleewan@wustl.edu.
Zitieren
APA
Patel, J., Daniels, E., Hawley, E., Consortium, W., & Kitcharoensakkul, M. (2025). JAK Inhibition in STAT1 Gain-of-Function-Associated Histoplasmosis and HLH. Journal of Clinical Immunology, 45(1). https://doi.org/10.1007/s10875-025-01900-3
Vancouver
Patel J, Daniels E, Hawley E, Consortium W, Kitcharoensakkul M. JAK Inhibition in STAT1 Gain-of-Function-Associated Histoplasmosis and HLH. Journal of Clinical Immunology. 2025;45(1). doi:10.1007/s10875-025-01900-3
BibTeX
@article{Patel2025,
author = {Patel, Jenny and Daniels, Elizabeth and Hawley, Eric and Consortium, WashU and Kitcharoensakkul, Maleewan},
title = {JAK Inhibition in STAT1 Gain-of-Function-Associated Histoplasmosis and HLH},
journal = {Journal of Clinical Immunology},
year = {2025},
volume = {45},
number = {1},
doi = {10.1007/s10875-025-01900-3}
}
EUVIMED